The fully linked HTML version of this article has now been published.
Development ePress online publication date 8 Apr 2004
doi: 10.1242/dev.01053
Research article: Development and disease
Vegfa is necessary for chondrocyte survival during bone development
Elazar Zelzer,
Roni Mamluk,
Napoleone Ferrara,
Randall S. Johnson,
Ernestina Schipani,
and
Bjorn R. Olsen*
* Author for correspondence (e-mail: bjorn olsen{at}hms.harvard.edu)
To directly examine the role of vascular endothelial growth factor (Vegfa) in cartilage development, we conditionally knocked out Vegfa in chondrocytes, using the Col2a1 promoter to drive expression of Cre recombinase. Our study of Vegfa conditional knockout (CKO) mice provides new in-vivo evidence for two important functions of Vegfa in bone formation. First, Vegfa plays a significant role in both early and late stages of cartilage vascularization, since Vegfa CKO mice showed delayed invasion of blood vessels into primary ossification centers and delayed removal of terminal hypertrophic chondrocytes. Second, Vegfa is crucial for chondrocyte survival, since massive cell death was seen in joint and epiphyseal regions of Vegfa CKO endochondral bones. Chondrocytes in these regions were found to upregulate expression of Vegfa in wild-type mice at the time when massive cell death occurred in the Vegfa CKO mice. The expression of the Vegfa receptors Npr1 and Npr2 in epiphyseal chondrocytes and lack of blood vessel reduction in the vicinity of the cartilaginous elements in the Vegfa CKO mice raise the possibility that the observed cell death is the result of a direct involvement of Vegfa in chondrocyte survival. Interestingly, the extensive cell death seen in Vegfa CKO null bones had a striking similarity to the cell death phenotype observed when hypoxia-inducible factor 1
(Hif1a) expression was abolished in developing cartilage. This similarity of cell death phenotypes and the deficient Vegfa production in Hif1a null epiphyseal chondrocytes demonstrate that Hif1 and Vegfa are components of a key pathway to support chondrocyte survival during embryonic bone development.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
C. L. Hammond and S. Schulte-Merker
Two populations of endochondral osteoblasts with differential sensitivity to Hedgehog signalling
Development,
December 1, 2009;
136(23):
3991 - 4000.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Eshkar-Oren, S. V. Viukov, S. Salameh, S. Krief, C.-d. Oh, H. Akiyama, H.-P. Gerber, N. Ferrara, and E. Zelzer
The forming limb skeleton serves as a signaling center for limb vasculature patterning via regulation of Vegf
Development,
April 15, 2009;
136(8):
1263 - 1272.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. R. Cuddihy, S. Ge, J. Zhu, J. Jang, A. Chidgey, G. Thurston, R. Boyd, and G. M. Crooks
VEGF-mediated cross-talk within the neonatal murine thymus
Blood,
March 19, 2009;
113(12):
2723 - 2731.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Yang, Q. Sun, Y. Teng, F. Li, T. Weng, and X. Yang
PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1{alpha} signaling and endoplasmic reticulum stress
Development,
November 1, 2008;
135(21):
3587 - 3597.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Shinoda, N. Ogata, A. Higashikawa, I. Manabe, T. Shindo, T. Yamada, F. Kugimiya, T. Ikeda, N. Kawamura, Y. Kawasaki, et al.
Kruppel-like Factor 5 Causes Cartilage Degradation through Transactivation of Matrix Metalloproteinase 9
J. Biol. Chem.,
September 5, 2008;
283(36):
24682 - 24689.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Schipani and T. L. Clemens
Hypoxia and the Hypoxia-Inducible Factors in the Skeleton
IBMS BoneKEy,
August 1, 2008;
5(8):
275 - 284.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. K. VanKoevering and B. O. Williams
Transgenic Mouse Strains for Conditional Gene Deletion During Skeletal Development
IBMS BoneKEy,
May 1, 2008;
5(5):
151 - 170.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Chen, M. Zhu, H. Awad, T.-F. Li, T.-J. Sheu, B. F. Boyce, D. Chen, and R. J. O'Keefe
Inhibition of {beta}-catenin signaling causes defects in postnatal cartilage development
J. Cell Sci.,
May 1, 2008;
121(9):
1455 - 1465.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Dai and A.B.M. Rabie
VEGF: an Essential Mediator of Both Angiogenesis and Endochondral Ossification
Journal of Dental Research,
October 1, 2007;
86(10):
937 - 950.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Provot, D. Zinyk, Y. Gunes, R. Kathri, Q. Le, H. M. Kronenberg, R. S. Johnson, M. T. Longaker, A. J. Giaccia, and E. Schipani
Hif-1{alpha} regulates differentiation of limb bud mesenchyme and joint development
J. Cell Biol.,
May 7, 2007;
177(3):
451 - 464.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. K. Mak, M.-H. Chen, T. F. Day, P.-T. Chuang, and Y. Yang
Wnt/{beta}-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation
Development,
September 15, 2006;
133(18):
3695 - 3707.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. Ward, B. M. Stone, L. T. Raetzman, and S. A. Camper
Cell Proliferation and Vascularization in Mouse Models of Pituitary Hormone Deficiency
Mol. Endocrinol.,
June 1, 2006;
20(6):
1378 - 1390.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Macotela, M. B. Aguilar, J. Guzman-Morales, J. C. Rivera, C. Zermeno, F. Lopez-Barrera, G. Nava, C. Lavalle, G. M. de la Escalera, and C. Clapp
Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin
J. Cell Sci.,
May 1, 2006;
119(9):
1790 - 1800.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Wedge, J. Kendrew, L. F. Hennequin, P. J. Valentine, S. T. Barry, S. R. Brave, N. R. Smith, N. H. James, M. Dukes, J. O. Curwen, et al.
AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer
Cancer Res.,
May 15, 2005;
65(10):
4389 - 4400.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Korc
Targeted Therapeutics in Pancreatic Cancer: A Ray of Hope
Clin. Cancer Res.,
January 1, 2005;
11(1):
410 - 411.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Stickens, D. J. Behonick, N. Ortega, B. Heyer, B. Hartenstein, Y. Yu, A. J. Fosang, M. Schorpp-Kistner, P. Angel, and Z. Werb
Altered endochondral bone development in matrix metalloproteinase 13-deficient mice
Development,
December 1, 2004;
131(23):
5883 - 5895.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Pfander, T. Kobayashi, M. C. Knight, E. Zelzer, D. A. Chan, B. R. Olsen, A. J. Giaccia, R. S. Johnson, V. H. Haase, and E. Schipani
Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development
Development,
May 15, 2004;
131(10):
2497 - 2508.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2004
